跳至主要内容
临床试验/PACTR201811722056449
PACTR201811722056449Other未知

EVALUATION OF THE ADDITION OF MORINGA OLEIFERA AS A NUTRITIONAL SUPPLEMENT ON THE ANTHROPOMETRIC, VIRAL LOAD AND CD4 COUNTS OF HIV PATIENTS ON ANTIRETROVIRAL THERAPY IN NIGERIA

KZ0 个研究点目标入组 172 人开始时间: 2018年9月25日最近更新:
适应症

试验速览

阶段
未知
状态
Other
发起方
入组人数
172

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
19 Year(s) 至 44 Year(s)(—)
性别
All

入选标准

  • 1.Being HIV sero-positive
  • 2.Patients = 18 years old
  • 3.Patients with CD4 counts = 500 cells/mm3
  • 4.Commenced ART at least for three months (Tenofovir + Lamivudine + Efavirenz combination).
  • 5.Be willing to give informed consent and comply with study protocol

排除标准

  • 1.Known allergy or intolerance to Moringa oleifera or placebo (cornstarch powder)
  • 2.Pregnant women
  • 3. Patients with CD4 counts > 500 cells/mm3
  • 4.Patients with active opportunistic infection
  • 5.Patients taking anti-coagulant, micronutrient or natural health product supplements within 30days of randomization
  • 6.Patients with poor or suboptimal adherence to ART medication
  • 7.For ease of monitoring and to achieve maximum compliance to study protocol, patients living outside Kano metropolis will be excluded.

研究者

发起方
KZ

相似试验